The Emerging Roles of Microparticles in Diabetic Nephropathy
Chen Chen Lu1, Kun Ling Ma1, Xiong Zhong Ruan2
1Institute of Nephrology, Zhong Da Hospital, School of Medicine, Southeast University, Nanjing City, Jiangsu Province, China.
Abstract:
Microparticles (MPs) are a type of extracellular vesicles (EVs) shed from the outward budding of plasma membranes during cell apoptosis and/or activation. These microsized particles then release specific contents (e.g., lipids, proteins, microRNAs) which are active participants in a wide range of both physiological and pathological processes at the molecular level, e.g., coagulation and angiogenesis, inflammation, immune responses. Research limitations, such as confusing nomenclature and overlapping classification, have impeded our comprehension of these tiny molecules. Diabetic nephropathy (DN) is currently the greatest contributor to end-stage renal diseases (ESRD) worldwide, and its public health impact will continue to grow due to the persistent increase in the prevalence of diabetes mellitus (DM). MPs have recently been considered as potentially involved in DN onset and progression, and this review juxtaposes some of the research updates about the possible mechanisms from several relevant aspects and insights into the therapeutic perspectives of MPs in clinical management and pharmacological treatment of DN patients.
Insights
Microparticles (MPs), tiny cell-derived vesicles, are implicated in diabetic nephropathy (DN) progression. Understanding their role offers new therapeutic avenues for kidney disease management in diabetes patients.
Area of Science:
- Cell biology
- Molecular medicine
- Nephrology
Background:
- Microparticles (MPs) are extracellular vesicles (EVs) released during cell apoptosis or activation, carrying bioactive molecules.
- MPs participate in physiological and pathological processes, including coagulation, angiogenesis, inflammation, and immune responses.
- Confusing nomenclature and classification hinder the comprehensive understanding of MPs.
Purpose of the Study:
- To review recent research on the involvement of MPs in diabetic nephropathy (DN) onset and progression.
- To explore potential mechanisms underlying MP activity in DN.
- To discuss therapeutic perspectives of MPs in the clinical management and treatment of DN.
Main Methods:
- Literature review of current research on microparticles and diabetic nephropathy.
- Analysis of studies investigating the molecular mechanisms of MP involvement in DN.
- Synthesis of findings related to therapeutic strategies involving MPs for DN.
Main Results:
- MPs are increasingly recognized for their potential role in the pathogenesis of DN.
- Specific MP contents and functions are being elucidated in the context of DN.
- Emerging evidence suggests MPs could be biomarkers or therapeutic targets for DN.
Conclusions:
- Further research into MP biology and function is crucial for understanding DN.
- MPs hold promise as diagnostic biomarkers and therapeutic agents for DN patients.
- Targeting MP-related pathways may offer novel treatment strategies for diabetic kidney disease.
